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Abstract
Aims/hypothesis Ageing is a major risk factor for develop-
ment of metabolic diseases such as type 2 diabetes. Identifi-
cation of the mechanisms underlying this association could
help to elucidate the relationship between age-associated pro-
gressive loss of metabolic health and development of type 2
diabetes. We aimed to determine molecular signatures during
ageing in the endocrine pancreas.
Methods Global gene transcription was measured in pancre-
atic islets isolated from young and old rats by Ilumina
BeadChip arrays. Promoter DNA methylation was measured
by SequenomMassArray in 46 genes that showed differential
expression with age, and correlations with expression
were established. Alterations in morphological and cel-
lular processes with age were determined by immuno-
histochemical methods.
Results Age-related changes in gene expression were found at
623 loci (>1.5-fold, false discovery rate [FDR] <5%), with a
significant (FDR<0.05) enrichment in genes previously impli-
cated in islet-cell function (Enpp1, Abcc8), type 2 diabetes
(Tspan8, Kcnq1), inflammatory processes (Cxcl9, Il33) and ex-
tracellular matrix organisation (Col3a1, Dpt). Age-associated
transcriptional differences negatively correlated with promoter
DNA methylation at several loci related to inflammation, glu-
cose homeostasis, cell proliferation and cell–matrix interactions
(Il33, Cxcl9, Gpr119, Fbp2, Col3a1, Dpt, Spp1).
Conclusions/interpretation Our findings suggest that a
significant proportion of pancreatic islets develop a
low-grade ‘chronic’ inflammatory status with ageing
and this may trigger altered functional plasticity. Fur-
thermore, we identified changes in expression of genes
previously linked to type 2 diabetes and associated
changes in DNA methylation that could explain their
age-associated dysregulation. These findings provide new in-
sights into key (epi)genetic signatures of the ageing process in
islets.
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Introduction
The normal process of ageing is a complex phenomenon as-
sociated with a variety of physiological alterations in the func-
tion of cells and organs. These alterations are thought to be
major determining risk factors for many traditionally adult-
onset diseases, including type 2 diabetes [1]. The progressive
decline with age of pancreatic islet function in humans, in the
presence of increasing insulin resistance, is thought to be a key
factor contributing to the pathophysiology of type 2 diabetes
[2]. For example, age-associated impairment in insulin secre-
tion has been demonstrated in rodents as well as in humans
[3]. When such insulin secretory defects are superimposed
over an increased need for insulin as observed in old age,
impaired glucose tolerance and type 2 diabetes may ensue.
However, the causes of age-related degenerative changes in
pancreatic islets remain poorly defined. Studies of cellular and
metabolic processes have led to theories that implicate in-
creased oxidative stress, impaired cell proliferation and apopto-
sis as causative factors [4].
More recently, epigenetic processes have been suggested to
underpin the loss of plasticity of cells that occurs during
ageing [5]. DNA methylation is a major epigenetic modifica-
tion, with essential roles in gene regulation and chromatin
organisation. Ageing has been correlated with both DNA
methylation gain [6] and loss [7], in a locus-dependent man-
ner. Moreover, there is a strong tissue specificity of age-
associated alterations in DNA methylation [8]. Altered DNA
methylation has been reported in pancreatic islets of type 2
diabetic patients compared with non-diabetic individuals
[9, 10]. Cell-type composition and function of pancreatic islets
change in response to physiological alterations with age
[11–15]. In the current study, we used isolated rat pancreatic
islets to study ageing in the context of the complex cell-type
interactions that characterise the endocrine pancreas. We pro-
filed genome-wide gene expression in pancreatic islets at two
time points—young (3 months of age) vs old (15 months of
age). We then established the extent to which differential ex-
pression with age could be explained by altered DNA
methylation by screening promoter methylation at a number
of selected genes. Our findings revealed age-associated gene
signatures of ‘inflammageing’ and type 2 diabetes. We sug-
gest that the detrimental events that occur during ageing and
increase the risk of impaired glucose homeostasis might be
triggered by a low-grade ‘chronic’ inflammatory status of
the endocrine pancreas.
Methods
Animals All procedures were conducted in accordance with
the 1986 British Home Office Animals Act. Each sample was
composed of islets isolated from two to four male Wistar rats
(Charles River, Margate, Kent, UK), which were killed at
3 months or 15months (±3 days) of age after overnight fasting
(n=4–10 samples per measurement).
Islet isolation, RNA extraction and purity assessment Iso-
lation of rat islets and RNA extraction was performed as de-
scribed [16]. Purity of rat islets samples was assessed by quan-
titative (q)RT-PCR quantification of the acinar-specific genes
Amy2 and Prss1 (see electronic supplementary material
[ESM] Fig. 1).
Expression microarray analysis Array profiling was per-
formed using the RatRef-12 Expression BeadChips (Illumina,
Little Chesterford, UK). Analysis of microarray data was per-
formed using GeneSpring GX 12.1 (Agilent, Santa Clara, CA,
USA). Signal intensity levels across arrays were normalised to
the 75th percentile, with baseline transformation to the median
intensity of all samples. Genes with signal intensities <50 after
normalisation were classified as non-expressed. Hierarchical
clustering was performed using a Euclidean distance metric
and a centroid distance rule. Criteria used for filtering ‘ageing
genes’ were: false discovery rate (FDR) <0.05 from an un-
paired t test following Benjamini–Hochberg correction for
multiple testing and 1.5-fold age-related change in expression.
Genes with age-related expression changes in rat islets that
had previously been associated with type 2 diabetes or islet
function (ESM Table 1) were identified by a keyword-based
search in OMIM (Online Mendelian Inheritance in Man),
genome-wide association study (GWAS) catalogue and
PubMed.
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qRT-PCR validation of expression microarrays RNA
(1 μg, n=10 samples per group) was used to synthesise cDNA
with the RevertAid H Minus Reverse Transcriptase kit
(Fermentas, Loughborough, UK). Quantification of gene ex-
pression was performed using the ABI Prism 7900 system
(Applied Biosystems, Foster City, CA, USA) and primers
for SYBR Green or TaqMan probes (Applied Biosystems)
(ESM Table 2). Fold changes in gene expression were calcu-
lated using the REST 2009 programme (Qiagen, Manchester,
UK) and normalised against Ppia, Taf2 and Hmbs, identified
as good internal controls from the microarray data.
Functional annotation and enrichment analysis This was
performed using DAVID v6.7 (Database for Annotation, Vi-
sualization and Integrated Discovery; http://david.abcc.
ncifcrf.gov/, accessed 16 July 2013) to assess whether there
was enrichment for genes implicated in particular biological
processes (background used: RatRef-12_V1_0_R4_
11222119_A). Enriched gene ontology (GO) terms with an
FDR<0.05 were considered significant. These terms were
then clustered semantically using the REViGO (Reduce and
Visualize GO) server [17], which removes redundancy. The
results obtained by REViGO were ordered according to log10
p values.
DNA methylation analysis using bisulfite MassArray
(Sequenom) Genomic DNA (1 μg) was extracted from islets
or BRIN-BD11 cells and was treated with sodium bisulfite
(EZ DNA methylation kit; Zymo, Irvine, CA, USA). Primer
pairs were designed using EpiDesigner (Sequenom, Ham-
burg, Germany) (ESM Table 2). MassArray analysis was per-
formed in triplicate according to manufacturer’s instructions
(Sequenom).
We measured DNA methylation levels at the promoter re-
gions of 46 genes that displayed age-related mRNA expres-
sion changes. We included genes identified as hits for type 2
diabetes by GWAS (Itgb6,Kcnq1, Tspan8), genes differential-
ly methylated between diabetic and control islets in humans
(Pyy, Tspan4, Lgals2, Spp1), genes implicated in monogenic
forms of diabetes (Abcc8) and genes that belong to the
enriched pathways described in Fig. 1c (for complete list see
ESM Table 3).
Pharmacolog ica l t rea tment BRIN-BD11 ce l l s
(GlaxoSmithKline, Stevenage, UK) were cultured as
described [16]. Cells (105/cm2) were seeded in T-75 flasks
24 h before the start of the treatment, which consisted of six
daily administrations of fresh media containing 100 μmol/l
zebularine (Sigma-Aldrich, St Louis, MO, USA) dissolved
in DMSO, or DMSO only as vehicle control. The analysis
was performed in nine of the 14 genes with inverse correlation
betweenDNAmethylation and gene expression. The remaining
five genes could not be analysed, as their methylation levels
were either very low or the genes were not expressed in BRIN-
BD11 cells in the presence or absence of zebularine.
Histological and immunohistochemical staining Staining
for β-galactosidase was performed on frozen sections using
the Senescence Cells Histochemical Staining kit (Sigma-
Aldrich). Sirius Red staining was performed on paraffin
sections as previously described [18].
All immunohistochemistry and immunofluorescence
stainingwas performed on paraffin sections (details are provided
in ESMTable 2). Slides without primary antibodies were used to
assess specificity of each staining (data not shown).
For histochemistry and immunohistochemistry staining
slides were scanned using a HamamatsuNanoZoomer scanner
then examined using the NDP.view software (Hamamatsu,
Japan). All islets from at least one section (n=4 biological
replicates per group) were inspected and scored by a researcher
blinded to the sample’s identity.
For immunofluorescent stainings image acquisition was
performed using a LSM510 Meta confocal laser scanning mi-
croscope (Carl Zeiss, Jena, Germany) and the ZEN 2009 soft-
ware (http://www.zeiss.com/microscopy/en_de/products/
microscope-software.html). At least ten randomly selected
islets were imaged for each section (n=4 biological
replicates per group). For glucagon/insulin double staining
total glucagon and insulin surface areas were measured using
the Visiopharm software (Visiopharm, Hoersholm, Denmark).
For regenerating islet-derived 3α (REG3A) and chemokine
(C-X-C motif) ligand 9 (CXCL9) stains the intensity of staining
was visually scored by three viewers blinded to the sample’s
identity and averages were used for statistical analysis.
Statistical analyses For qRT-PCR data statistical analysis
was performed using the REST 2009 programme (Qiagen,
Manchester, UK). All other statistical tests were performed
using the GraphPad 5.04 software (http://www.graphpad.com).
A p value of <0.05 was considered statistically significant.
Results
Age-related gene expression changes in rat islets We ge-
nerated microarray datasets of islets isolated from 3-month-
old (3M) and 15-month-old (15M) male rats, using Illumina’s
Expression BeadChips, which interrogate ~21,900 genes. In-
formation on the preparation and purity of the rat islet samples
is summarised in the Methods and ESM Fig. 1. We identified
623 genes out of the 16,885 genes expressed in islets, which
had significant age-related transcriptional changes (>1.5-fold,
FDR<0.05). There was a strong bias for age-associated up-
regulation (525 genes vs 98 downregulated genes; sign test
p=2.76×10−65). The complete list of genes with significant
age-related changes in expression is depicted as a heat map in
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Fig. 1a and is provided in full in ESM Table 4. These 623
genes include 44 that have been previously implicated in beta
cell function and/or linked to type 2 diabetes through GWAS
(ESM Table 1). For microarray validation, expression of 26
genes (shown in red in ESM Table 4, and including six of
those listed in ESM Table 1 [Cartpt, S100a6, Ptger3, Reg3a,
Pyy and Npy]) was measured by qRT-PCR. We found a strong
positive correlation between microarray and qRT-PCR mea-
surements (R=0.6655, p=4.14×10−4 Fig. 1b).
Using DAVID functional annotation, followed by
REViGO filtering (see Methods), we found that genes upre-
gulated with age were significantly enriched for cellular pro-
cesses related to immune and inflammatory responses and
extracellular matrix organisation. According to the criteria
used there were only three biological processes significantly
enriched in genes downregulated with age: regulation of res-
ponse to food, cell–cell signalling and neuron recognition (see
Fig. 1c for the top biological processes influenced by age and
ESM Table 5 for the comprehensive list).
Age-related changes in DNA methylation of differentially
expressed loci To test the hypothesis that the mRNA expres-
sion changes with age were associated with alterations in
DNAmethylation levels at promoter regions we used bisulfite
MassArray assays [19] to measure DNAmethylation levels at
46 loci (36 showed upregulation with age and ten displayed
downregulation with age; see Methods for selection criteria
and ESM Table 3 for complete list).
The methylation status of 26 of the loci studied (56.5%)
changed with age (ESM Table 3). However, only 19 showed
an absolute difference in methylation above 5% (averaged
across all CpG sites), with a maximum DNA methylation
change of 28.4% (ESM Table 3). Of these 19 genes, 14 de-
monstrated a direction of change consistent with the age-
Fig. 1 Genes with age-related
changes in mRNA expression in
rat islets. (a) Heat map depicting
genes differentially expressed
between young and old islets. (b)
Biological validation by qRT-
PCR for 26 genes (R=0.6655,
p=4.14×10−4). (c) Top-scoring
biological processes enriched in
genes upregulated with age (black
bars) or downregulated with age
(white bars) (see also ESM
Table 5). Between parentheses are
indicated three genes with the
highest age-related fold
expression changes. The dotted
line corresponds to p=0.05. AIR,
acute inflammatory response
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associated effects on transcription (i.e. loss or gain of methy-
lation correlating with increased or decreased gene expres-
sion, respectively) (Fig. 2, ESM Fig. 2 and ESM Table 3).
Notably, several genes with altered DNA methylation belong
to enriched pathways shown in Fig. 1c (i.e. inflammation [Il33,
Cxcl9], glucose homeostasis [Gpr119, Fbp2] and extracellular
matrix organisation [Col3a1, Dpt, Spp1]) (ESM Table 5).
To address the relationship between methylation and tran-
scription we used the DNA methylation inhibitor zebularine
[20] in BRIN-BD11 insulin-secreting cells. After 6 days of
treatment with 100 μmol/l zebularine, we found significant
reductions in DNA methylation at the promoter regions of
all of the nine loci tested (ESM Fig. 3a; see Methods for
exclusion criteria of five loci out of the 14). We then measured
by qRT-PCR the corresponding mRNA levels and found that
zebularine treatment led to a substantial increase in expression
of five genes (Fbp2, S100a4, Lgals1, Tf andCxcl9), consistent
with demethylation leading to increased transcription. In con-
trast, zebularine treatment had no effect on the expression of
the remaining four genes (Il33, Pah, C4b and Col3a1) (ESM
Fig. 3b).
We also measured DNA methylation of LINE-1 transpo-
sable retroelements, which constitute almost 23% of the rat
genome [21]. We found a significant 5.5% loss of DNA
methylation with age (ESM Table 3).
Tissue and cellular changes associated with ageing As
shown previously, DAVID analysis revealed that a number
Fig. 2 Genes with significant
age-related differences in DNA
methylation (>5%) at promoter
regions that demonstrated an
inverse relationship with mRNA
expression levels: Gpr119 (a),
Fbp2 (b), S100a4 (c), Il33 (d),
Pah (e), Lgals1 (f),Mgst1 (g),Dpt
(h), C4b (i), Col3a1 (j), Prss35
(k), Tf (l), Spp1 (m) and Cxcl9
(n). White squares, 3M samples;
black squares, 15M samples.
Horizontal bars indicate mean
values. *p<0.05, **p<0.01 and
***p<0.001 for 15M vs 3M, by
Mann–Whitney tests
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of cellular processes related to wound healing, immune res-
ponses and extracellular matrix organisation (Fig. 1c) are al-
tered between young and aged islets. These findings prompted
us to investigate signs of inflammation and fibrosis within the
islets of aged rats.
First, we confirmed by qRT-PCR that a number of genes
corresponding to the enriched biological processes were dif-
ferentially expressed in an extended cohort of samples (13
genes highlighted in yellow in ESM Table 4). At the protein
level we showed increased expression of two of the top five
genes upregulated with age at the mRNA level, Reg3a and
Cxcl9 (Fig. 3), related to wound response and immune
response, respectively.
Second, to investigate further the extent to which islet mor-
phology and cellular function is changed with age, we evalu-
ated markers of cellular senescence, macrophage infiltration,
fibrosis and beta-to-alpha cell ratios, by (immuno)/histochem-
ical staining in sections of young and old islets and performed
a semiquantitative analysis (Fig. 4). Strong staining for
β-galactosidase, a known marker of cellular senescence
[22], was seen in ~20% of old islets, but was undetectable in
any of the islets from young rats (Fig. 4a). Deposition of
collagen, measured by Sirius Red staining, was observed in
young islets at a low frequency (~7% of islets with moderate
degree of collagen staining) and increased with age (~42% of
islets with moderate to severe staining) (Fig. 4b). Macrophage
infiltration, assessed by CD68 immunostaining, a pan-marker
of all macrophage lineages [23], was almost exclusively found
in old islets (at a frequency of ~27%) (Fig. 4c). To further
phenotype the infiltrating macrophages we stained for nitric
oxide synthase 2 (NOS2, also denoted as iNOS), a marker of
the ‘classically activated’, proinflammatory M1 macrophages
[24] (ESM Fig. 4a), and for arginase 1 (ARG1), a marker for
the ‘alternatively-activated’ anti-inflammatory M2 macro-
phages [24] (ESM Fig. 4b). Both types of macrophages were
present in ~24% of the islets from old rats. Glucagon and
insulin staining was performed to assess whether aged pancre-
atic islets maintain the proportion of alpha and beta cells seen
in young islets (Fig. 4d). Our results suggest that the known
age-related increase in beta cell mass [25] was not accompa-
nied by a concomitant increase in alpha cell mass, leading to a
difference in cell composition between islets from young rats
and those from old rats (Fig. 4d).
Discussion
It is well established that ageing is associated with the func-
tional decline of endocrine organs and therefore a risk factor
for metabolic conditions, such as type 2 diabetes, in later life.
Little work has been done to define the effects of ageing on the
transcriptome of the endocrine pancreas and how epigenetic
Fig. 3 Immunofluorescence
analysis of candidate proteins that
exhibit age-related changes in
mRNA expression in rat islets
(red channel): REG3A (a) and
CXCL9 (b). For both figure parts
representative islets are depicted,
scored as weakly stained (3M)
and strongly stained (15M). The
composite images visualise
pancreatic beta cells stained with
insulin (green) and nuclei stained
with DAPI (blue). Scale bars,
100 μm. The histograms show the
quantification for each stain
(white bars, 3M; black bars,
15M). Data represent the mean of
n=4 samples per group; error bars
represent SEM; *p<0.05 for 15M
vs 3M, by Mann–Whitney tests
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mechanisms could contribute to these effects. In this study we
analysed the dynamics of gene transcription during ageing of
the endocrine pancreas and measured promoter DNA methy-
lation at a selected number of loci with age-associated tran-
scriptional changes. We found age-related molecular signa-
tures of ‘inflammageing’ and ‘type 2 diabetes’, with parallel
changes in DNA methylation of genes contributing to this
effect. We propose that these (epi)genetically regulated ‘sig-
nature’ genes represent novel mediators of the age-associated
decline in islet-cell function.
We identified 3.7% genes within the islet transcriptome that
were differentially expressed between young and old islets, by
1.5-fold or more, with the majority (84.3%) showing increases
in expression with age. Pathway analysis revealed an enrich-
ment of upregulated genes implicated in inflammation and
immune responses (e.g. genes encoding homeostatic and in-
flammatory chemokines, interferon and interleukin,
complement genes and genes encoding MHC molecules,
which are involved in antigen presentation), suggestive of
age-associated increases in endocrine pancreas inflammation
(or inflammageing). Inflammageing, a term used to describe
an imbalance between inflammatory and anti-inflammatory
networks that causes lifelong antigenic burden and exposure
to damaging agents, is thought to be a major driving force for
frailty and common age-related pathologies [26]. Our findings
lead us to propose that inflammageing may contribute to the
known age-associated decline in beta cell function and conse-
quential increase in type 2 diabetes risk. There is a substantial
lack of functional studies that link those processes to endo-
crine function. Importantly, a transgenic mouse with increased
expression of Ccl2 (encoding chemokine [C-C motif] ligand
2) in their beta cells developed diabetes [27]; this is consistent
with our observed age-related upregulation of Ccl2 being de-
trimental for endocrine pancreatic function. Our findings are
Fig. 4 Histochemical and
immunohistochemical analysis of
3M and 15M rat pancreases. (a)β-
Galactosidase (β-gal) staining for
cell senescence. The dotted lines
outline pancreatic islets. (b) Sirius
Red staining for collagen. Arrows
indicate deposition of collagen. (c)
Immunohistochemical staining for
the macrophage marker CD68.
Arrows indicate accumulation of
macrophages. (d) Double
immunostaining for glucagon
(red) and insulin (green). Scale
bars, 200 μm (a–c) and 100 μm
(d). The histograms show the
quantification for each stain
(white bars, 3M; black bars, 15M).
Data represent the mean of n=4
samples per group; error bars
represent SEM; *p<0.05 for 15M
vs 3M, by Mann–Whitney tests
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also consistent with studies showing that cells undergoing
senescence start secreting a large number of pro-
inflammatory cytokines and chemokines, as part of the so-
called ‘senescence-associated secretory phenotype’ (SASP)
[28]. We identified several genes that encode SASP proteins
and that were upregulated with age in rat islets, including
Igfbp6, Mmp12, Mmp14, Timp2 and Fn1.
Many other genes that exhibited transcriptional dysregula-
tion with age have been linked previously with type 2 diabetes
(ESMTable 1). For example, microarray studies performed on
human pancreatic islets isolated from patients with type 2
diabetes and glucose-tolerant controls identified, among other
changes, overexpression of ENPP1, TSPAN4, TSPAN8,
CSRP1, REG3A and REG3G [29, 30], genes that were also
upregulated with age in our study. Some of the genes identi-
fied as being differentially expressed with age have been pre-
viously implicated in type 2 diabetes through GWAS [31].
These include TSPAN8, KCNQ1 and ITGB6 loci (upregulated
with age in rat islets) and some of these polymorphisms have
been predicted to affect beta cell function. Other genes
expressed differentially with age have been previously impli-
cated in endocrine pancreas function (ESM Table 1). These
genes could therefore represent novel mediators of the age-
associated decline in islet cell function.
As expected from the nature of this study, we found a
number of gene expression ‘signatures’ of the ageing process.
Fifteen of the genes upregulated with age (C1qa, C1qb, Ctss,
S100a6, Lgals3, Mgst1, S100a4, Fcgr2a, Gbp2, Il33, Litaf,
Serping1, Spp1, Laptm5 and Txnip) had similar age-related
gene expression changes to the ones reported in a recent
meta-analysis of mouse, rat and human tissues (over ten tis-
sues but not including pancreatic islets) [32, 33]. These genes
therefore appear to be part of a common signature of ageing
across tissues that include a total of 73 genes [32, 33].
Age-related changes in DNA methylation in the endocrine
pancreas have not been reported prior to this study. We fo-
cused our analysis on a restricted number of loci (n=46),
based on the microarray differential expression analysis, with
the aim of establishing correlations between DNA promoter
methylation and transcriptional activity. Globally, 19 of the 46
loci analysed (41%) showed absolute differences in methyla-
tion of between 5% and 28%. Fourteen of the 19 differentially
methylated genes (74%) demonstrated a direction of change
consistent with differences in expression, suggesting that
DNA methylation may contribute to the transcriptional
changes. Notably, 13 of these 14 loci reflected hypomethy-
lation with age and were associated with increased expres-
sion. These changes were observed at loci related to
‘inflammageing’ and endocrine function. Global analysis
of DNA methylation, as measured by methylation levels of
LINE-1 repeats, further suggested that hypomethylation
might be an epigenetic hallmark of ageing in rat islets.
Importantly, a major preponderance for loss of DNA
methylation has been observed recently in pancreatic islets
of type 2 diabetes patients [9, 10].
Our current study has one important limitation, which is the
use of islet cells instead of purified cell types. A clear advan-
tage of using islet cells is that this reflects the physiology of
the endocrine pancreas and takes into account the milieu of
insulin-secreting cells. However, the transcriptomic and epi-
genetic data analyses are made more complex given potential
confounding effects brought about by morphology and cell-
type composition changes with age. In this study, we found
clear evidence for cellular senescence, collagen deposition
and macrophage infiltration in a significant proportion of aged
islets (affecting ~20%, ~ 42% and ~27% of all islets, respec-
tively). Associated with these morphological changes, 11 col-
lagen genes were upregulated in our dataset (ESM Table 4) as
was the macrophagemarker CD68 (Fig. 4c). Importantly, age-
related morphological changes in the pancreatic islets, such as
beta cell hyperplasia and intra-insular fibrosis with accumula-
tion of macrophages, have been recognised to occur sponta-
neously in aged (predominantly male) rats fed ad libitum [14,
15]. Similar morphological changes have also been reported in
several rat models of diabetes and in obese rat strains [34–36].
Pancreatic islet pathology is highly variable in patients with
type 2 diabetes, with moderate changes in beta cells, islet
fibrosis and amyloidosis being commonly reported [14].
These morphological changes are likely to have an impact
on DNA methylation patterns. Whether the altered DNA
methylation seen in this current study reflects cell-type com-
position differences or relates to transcriptional activity only,
or a combination of both, is difficult to ascertain. Our studies
using a demethylating agent in an insulin-secreting cell line
suggest that loss of DNAmethylation might be responsible, at
least in part, for the observed transcriptional changes at five
loci (Fbp2, S100a4, Lgals1, Tf and Cxcl9). Cxcl9 is of parti-
cular interest as it is upregulated at both the mRNA (ranking
as second highest gene upregulated with age in our dataset;
ESM Table 4) and protein level (Fig. 3b) and is
hypomethylated with age. CXCL9 is a small cytokine that
has been shown to play an anti-fibrotic role in experimental
chronic pancreatitis in rats and is a promising therapeutic tar-
get in pancreatic fibrosis [37]. S100a4 (encoding S100 cal-
cium binding protein a4) has been shown to increase with
age in a number of tissues [32]. However, it has not previously
been established whether this is associated with changes in
DNA methylation. Whether or not the age-related changes
in DNA methylation observed at these loci are directly linked
to the increased risk for type 2 diabetes will need to be
established in future studies.
In conclusion, our study demonstrates that ageing leads to a
relatively small number of transcriptional alterations in the
endocrine pancreas, associated with an ‘inflammageing’ phe-
notype and type 2 diabetes signatures. The only other micro-
array analysis investigating the impact of ageing on the
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pancreatic islet transcriptome (interrogating ~13,000 mouse
genes) [38] did not reported the same findings (there are se-
veral important differences between the two studies, including
species, age time points, transcriptomic coverage and islet cell
purity) and did not link the transcriptome to changes in epige-
netic alterations. A very recent study of beta cell ageing in the
mouse identified ~6,000 differentially expressed genes and
over 14,000 differentially methylated regions, the majority
of which were located more than 1 kb distal to transcriptional
start sites. This study was conducted in sorted beta cells, there-
fore the impact of cellular processes described in our study
(e.g. macrophage infiltration, collagen deposition) during
ageing were missed [39]. We suggest that age-associated
low-grade inflammation is linked with cellular (e.g. fibrosis)
and metabolic dysfunction (e.g. de-regulation of genes in-
volved in type 2 diabetes pathogenesis). These findings
indicate that the local pancreatic environment (e.g. inflam-
mation and fibrosis), in addition to systemic effects that
occur with age, may be a major cause for the age-depen-
dent decline of endocrine function. Furthermore, we pro-
pose that alterations in promoter DNA methylation can
modulate these processes, although causal relationships
need to be established.
Future studies aimed at assessing the biological roles of the
genes highlighted in this study, using in vitro assays and/or
in vivo animal models, have the potential to expand our know-
ledge on type 2 diabetes pathogenesis. It will be important to
investigate whether the samemechanisms reported in this study
are also observed in aged human islets.
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